ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Thursday, 12 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Earnings Call Transcript

Platinum Industries Earnings Call Transcript: Key Takeaways

Platinum Industries Q1 FY27 consolidated revenue fell 5.6% YoY to INR 108.9 Cr. Management describes this as a transition phase focused on capacity ramp-up and product mix improvement toward lead-free solutions.

Guidance and delivery
Management target Revenue 40.0% FY27
Highlights
Revenue growthFY27 target 30-40% growth despite Q1 de-growth.
MarginsEBITDA target 13-15%; PAT target 11-12%.
Demand visibilityPipe demand recovery noted starting August; farmers/retailers resuming purchases.
Management confidenceHigh confidence in long-term scaling and operational utilization.

Growth

Consolidated Revenue: INR 108.9 Cr (-5.6% YoY). EBITDA: INR 13.44 Cr (-11.3% YoY). PAT: INR 11.13 Cr (-14.8% YoY).

Outlook

Maintains 30-40% FY27 revenue growth guidance. Egypt facility commissioning by Dec 2026. Palghar facility peak potential INR 700-800 Cr.

Risks

Shipping delays and high freight costs due to war impact margins; temporary demand degrowth in the pipe sector.

Last quarter's promises, checked

Delivered

  • EBITDA margin 13-15% → delivered 12.3% (= MISS)
  • Oleo revenue start April 2026 → delivered INR 5.3 Cr in Q1 (= BEAT)
  • PAT margin 11-12% → delivered 10.2% (= MISS)

Partly delivered

  • Egypt commissioning Q3 FY27 → Reconfirmed for Dec 2026 (= PARTIAL)

Missed

  • Targeting 40% FY27 revenue growth → delivered -5.6% YoY in Q1 (= MISS)
Source

Earnings Call Transcript filed with BSE, NSE: PLATIND. Summary written with AI assistance from the document.

Read the document ↗

Platinum Industries Ltd: key numbers

Share price
₹215.50
Market cap
₹1,184 Cr
Revenue (annual)
₹450.4 Cr
Net profit (annual)
₹51.96 Cr
P/E (TTM)
25.5×Sector 35.5×
Promoter holding
70.03%+0.00% QoQ
FII holding
0.18%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Platinum Industries Ltd

All →
11:30 IST BSE
Partnership

Platinum Industries Partnership

Platinum Industries' subsidiary, Rivadu Lifesciences, entered an exclusive sale/purchase agreement with Korea-based CAREGEN Co., Ltd. The partnership targets the Indian market for Caregen's functional food products.

From
CAREGEN Co., Ltd., Korea